NPS Pharmaceuticals (NPSP)
NPS Pharmaceuticals News
NPS Pharmaceuticals to Present at Jefferies Global Healthcare Conference
Business Wire about a day agoNPS Pharmaceuticals, Inc. will present at the Jefferies 2012 Global Healthcare Conference in New York on Monday, June 4, 2012 at 11:30 a.m. ET. The presentation will be available as a live webcast with a replay available approximately three hours after the presentation has concluded.
[video] NPS Pharma CEO: Market Recognizing Pipeline Potential
about 3 days agoNPS PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
about 9 days agoU.S. Stock Options With Biggest Changes in Implied Volatility
about 10 days agoDigestive Disease Week Presentations Support Therapeutic Potential for Gattex (teduglutide) as Novel Treatment for Adult Short Bowel Syndrome
Business Wire about 10 days agoNPS Pharmaceuticals, Inc. , a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today reported the presentation of data at the Digestive Disease Week® meeting held May 19-22 in San Diego.
[video] Stocks Under $10: Healthcare Name on Sale
about 14 days agoOn The Fly: Analyst Initiation Summary
about 24 days agoCanaccord Genuity Starts NPS Pharmaceuticals Inc. (NPSP) at Buy
Street Insider about 24 days agoNPS Pharmaceuticals coverage assumed with a Buy at Canaccord
about 24 days agoNeedham & Company Reiterates a 'Buy' on NPS Pharmaceuticals (NPSP); Awaiting Date for Gattex FDA AdCom Meeting
Street Insider about 27 days agoNPS Pharmaceuticals, Inc. (NPSP) Misses Q1 EPS by 1c
Street Insider about 27 days agoNPS Pharmaceuticals Earnings Call scheduled for 5:00 pm ET today
about 27 days agoNPS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
about 27 days agoNPS Pharmaceuticals Reports First Quarter 2012 Financial Results
Business Wire about 27 days agoNPS Pharmaceuticals, Inc. , a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today reported its re
You may also be interested in these NPSP related companies
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| NPSP | 7.93 | -0.17 | -2.10% | 697.49M |
| NPM | 15.24 | +0.03 | +0.20% | |
| NPK | 66.00 | -0.43 | -0.65% | 457.04M |
| NNBR | 7.68 | -0.39 | -4.83% | 136.79M |
| NNA | 2.585 | -0.01 | -0.19% | 104.95M |
| NMT | 15.12 | -0.11 | -0.71% | |
| NMRX | 8.92 | -0.06 | -0.67% | 136.14M |
| NMR | 3.27 | -0.05 | -1.51% | 12.16B |
| NMM | 13.98 | -0.37 | -2.58% | 672.87M |
| NMD | 12.32 | +0.01 | +0.08% |
